Ignite Creation Date:
2025-12-24 @ 6:45 PM
Ignite Modification Date:
2025-12-31 @ 2:31 AM
Study NCT ID:
NCT01461057
Status:
COMPLETED
Last Update Posted:
2018-08-09
First Post:
2011-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2015-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-26
First Submit QC Date:
None
Study First Post Date:
2011-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-19
Results First Submit QC Date:
None
Results First Post Date:
2016-06-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-13
Last Update Post Date:
2018-08-09
Last Update Post Date Type:
ACTUAL